Altis Labs Raises $25M Series A for AI Oncology Imaging — SkimNews
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- Altis Labs raised a $25 million Series A round, with CEO Felix Baldauf-Lenschen leading the company
- Altis Labs' AI model analyzes CT scans taken during oncology trials and produces predictions tied to patient survival, positioning the company as an AI software vendor for drug development
Why it matters: The $25M Series A gives Altis Labs capital to scale its CT-imaging AI platform, which generates patient-survival predictions from oncology-trial scans — a capability pharma sponsors can integrate into drug-development workflows to inform trial decisions using imaging-derived endpoints.
Ask SkimNews